Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Back to the forum  2018-07-16 07:32 CEST (UTC+2h)

BE study designs for ANVISA [Regulatives / Guidelines]

posted by Mahesh M - India, 2018-07-11 09:11  - Posting: # 19030
Views: 145

Dear Helmut,

Do you have any references for below (NTID for ANVISA)

» ANVISA 95% CI within 80-125%.

Regards
Mahesh

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,527 posts in 3,938 threads, 1,190 registered users;
online 34 (0 registered, 34 guests [including 26 identified bots]).

Mankind has survived all catastrophes.
It will also survive modern medicine.    Gerhard Kocher

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed